PLI scheme may trigger investments worth Rs 50,000 crore into pharma sector

According to the people, 86 companies have applied to start production of bulk drugs listed under the PLI scheme so far, said sources

Topics
PLI scheme | Investments | Indian pharma companies

Sohini Das  |  Mumbai 

Major pharma players have warmed up to the bulk drug production-linked incentive (PLI) scheme. According to industry insiders, once the second tranche of the scheme covering formulations comes online, it may trigger investments worth Rs 50,000 crore.

There are two PLI schemes for the pharma sector — one for bulk drugs, and another covering formulations, biologics, complex generics, etc. According to the people, 86 companies have applied to start production of bulk drugs listed under the PLI scheme so far, said sources. “About 86 proposals have gone to the department of ...

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, February 11 2021. 06:10 IST
RECOMMENDED FOR YOU